Cost-effectiveness analysis of guidelines for antihypertensive care in Finland

Table 3 Main operationalised differences between the PCP and ACCG scenarios.

ACCG scenario	Monitoring	lifestyle counselling	single antihypertensive drug	two antihypertensive drugs	three antihypertensive drugs
BPG 0	Yes	No	No	No	No
BPG 1	No	Yes	No	No	No
BPG 2	No	Yes	Possible*	Possible	Possible
BPG 3	No	Yes	Yes	Possible	Possible
PCP scenario	monitoring	lifestyle counselling	single antihypertensive drug	two antihypertensive drugs	three antihypertensive drugs
BPG 0	Possible	No	Possible	Possible	Possible
BPG 1	Possible	No	Possible	Possible	Possible
BPG 2	Possible	No	Possible	Possible	Possible
BPG 3	Possible	No	Possible	Possible	Possible

* In this table, 'Possible' refers to the potential use of interventions. In the ACCG scenario, this refers to the fact that treatment with antihypertensive pharmacological therapy can be considered in this case. For the PCP scenario, data from H2000 suggest that use of antihypertensive pharmacological therapy did occur in all BP groups, as did monitoring.

ISSN: 1472-6963